Roche confirms full year targets as first-half sales fall

Roche reaffirmed its full-year targets, but first-half sales fell in Swiss franc terms as a stronger domestic currency weighed on reported results. The update suggests underlying performance may be steadier than headline numbers, though FX remains a near-term headwind for investors monitoring reported growth.

Analysis

Roche reaffirmed its full-year targets, but first-half sales fell in Swiss franc terms as a stronger domestic currency weighed on reported results. The update suggests underlying performance may be steadier than headline numbers, though FX remains a near-term headwind for investors monitoring reported growth.